Orsobio, Inc
Clinical trials sponsored by Orsobio, Inc, explained in plain language.
-
New obesity drug TLC-6740 enters first human trials
Disease control Recruiting nowThis early-stage study tests a new drug called TLC-6740 in healthy volunteers and people with obesity, with or without type 2 diabetes. The main goals are to check safety, how the body processes the drug, and to get an early look at whether it helps with weight loss or blood suga…
Phase: PHASE1 • Sponsor: OrsoBio, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug TLC-1180 tested in healthy people for first time
Knowledge-focused Recruiting nowThis early-phase trial is testing a new drug called TLC-1180 in 288 healthy adults aged 18 to 55. The main goal is to check if the drug is safe and how the body handles it, not to treat any disease. Participants will receive either the drug or a placebo, and researchers will moni…
Phase: PHASE1 • Sponsor: OrsoBio, Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC